Title |
TGF-β in pancreatic cancer initiation and progression: two sides of the same coin
|
---|---|
Published in |
Cell & Bioscience, August 2017
|
DOI | 10.1186/s13578-017-0168-0 |
Pubmed ID | |
Authors |
Wei Shen, Guo-qing Tao, Yu Zhang, Bing Cai, Jian Sun, Zhi-qiang Tian |
Abstract |
Pancreatic cancer is highly lethal malignant tumor with characterised rapid progression, invasiveness and resistance to radiochemotherapy. Transforming growth factor-β (TGF-β) signaling plays a dual role in both pro-tumorigenic and tumor suppressive of pancreatic cancer, depending on tumor stage and microenvironment. TGF-β signaling components alteration are common in pancreatic cancer, and its leading role in tumor formation and metastases has received increased attention. Many therapies have investigated to target TGF-β signaling in the preclinical and clinical setting. In this review, we highlight the dual roles of TGF-β and touch upon the perspectives on therapeutic target of TGF-β signaling in pancreatic cancer. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 133 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 23 | 17% |
Student > Master | 23 | 17% |
Student > Bachelor | 18 | 14% |
Student > Doctoral Student | 11 | 8% |
Researcher | 8 | 6% |
Other | 14 | 11% |
Unknown | 36 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 42 | 32% |
Medicine and Dentistry | 18 | 14% |
Agricultural and Biological Sciences | 16 | 12% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
Immunology and Microbiology | 4 | 3% |
Other | 6 | 5% |
Unknown | 42 | 32% |